275 related articles for article (PubMed ID: 28195307)
1. Effect of obeticholic acid on liver regeneration following portal vein embolization in an experimental model.
Olthof PB; Huisman F; Schaap FG; van Lienden KP; Bennink RJ; van Golen RF; Heger M; Verheij J; Jansen PL; Olde Damink SW; van Gulik TM
Br J Surg; 2017 Apr; 104(5):590-599. PubMed ID: 28195307
[TBL] [Abstract][Full Text] [Related]
2. Unaltered Liver Regeneration in Post-Cholestatic Rats Treated with the FXR Agonist Obeticholic Acid.
de Haan LR; Verheij J; van Golen RF; Horneffer-van der Sluis V; Lewis MR; Beuers UHW; van Gulik TM; Olde Damink SWM; Schaap FG; Heger M; Olthof PB
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33578971
[No Abstract] [Full Text] [Related]
3. Bile salts predict liver regeneration in rabbit model of portal vein embolization.
Hoekstra LT; Rietkerk M; van Lienden KP; van den Esschert JW; Schaap FG; van Gulik TM
J Surg Res; 2012 Dec; 178(2):773-8. PubMed ID: 22763217
[TBL] [Abstract][Full Text] [Related]
4. Enhanced tumor growth after portal vein embolization in a rabbit tumor model.
Hoekstra LT; van Lienden KP; Verheij J; van der Loos CM; Heger M; van Gulik TM
J Surg Res; 2013 Mar; 180(1):89-96. PubMed ID: 23149224
[TBL] [Abstract][Full Text] [Related]
5. Use of an absorbable embolization material for reversible portal vein embolization in an experimental model.
Olthof PB; Huisman F; van Golen RF; Cieslak KP; van Lienden KP; Plug T; Meijers JC; Heger M; Verheij J; van Gulik TM
Br J Surg; 2016 Sep; 103(10):1306-15. PubMed ID: 27477877
[TBL] [Abstract][Full Text] [Related]
6. Short-term effects of combined hepatic vein embolization and portal vein embolization for the induction of liver regeneration in a rabbit model.
van Lienden KP; van den Esschert JW; Rietkerk M; Heger M; Roelofs JJ; Lameris JS; van Gulik TM
J Vasc Interv Radiol; 2012 Jul; 23(7):962-7. PubMed ID: 22633622
[TBL] [Abstract][Full Text] [Related]
7. Liver regeneration following repeated reversible portal vein embolization in an experimental model.
Tranchart H; Koffi GM; Gaillard M; Lainas P; Poüs C; Gonin P; Nguyen TH; Dubart-Kupperschmitt A; Dagher I
Br J Surg; 2016 Aug; 103(9):1209-19. PubMed ID: 27256140
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling in human precision cut liver slices in response to the FXR agonist obeticholic acid.
Ijssennagger N; Janssen AWF; Milona A; Ramos Pittol JM; Hollman DAA; Mokry M; Betzel B; Berends FJ; Janssen IM; van Mil SWC; Kersten S
J Hepatol; 2016 May; 64(5):1158-1166. PubMed ID: 26812075
[TBL] [Abstract][Full Text] [Related]
9. Obeticholic acid protects mice against lipopolysaccharide-induced liver injury and inflammation.
Xiong X; Ren Y; Cui Y; Li R; Wang C; Zhang Y
Biomed Pharmacother; 2017 Dec; 96():1292-1298. PubMed ID: 29174575
[TBL] [Abstract][Full Text] [Related]
10. FXR agonist obeticholic acid induces liver growth but exacerbates biliary injury in rats with obstructive cholestasis.
van Golen RF; Olthof PB; Lionarons DA; Reiniers MJ; Alles LK; Uz Z; de Haan L; Ergin B; de Waart DR; Maas A; Verheij J; Jansen PL; Damink SWO; Schaap FG; van Gulik TM; Heger M
Sci Rep; 2018 Nov; 8(1):16529. PubMed ID: 30409980
[TBL] [Abstract][Full Text] [Related]
11. A rabbit model for selective portal vein embolization.
de Graaf W; van den Esschert JW; van Lienden KP; Roelofs JJ; van Gulik TM
J Surg Res; 2011 Dec; 171(2):486-94. PubMed ID: 20691990
[TBL] [Abstract][Full Text] [Related]
12. BestFLR Trial: Liver Regeneration at CT before Major Hepatectomies for Liver Cancer-A Randomized Controlled Trial Comparing Portal Vein Embolization with
Luz JHM; Veloso Gomes F; Costa NV; Vasco I; Coimbra E; Luz PM; Marques HP; Coelho JS; Mega RMA; Ribeiro VNTV; da Costa Lamelas JTR; de Sampaio Nunes E Sobral MM; da Silva SRG; de Teixeira Carrelha AS; Rodrigues SCC; de Figueiredo AAFP; Santos MV; Bilhim T
Radiology; 2021 Jun; 299(3):715-724. PubMed ID: 33825512
[TBL] [Abstract][Full Text] [Related]
13. Liver regeneration after portal vein embolization using absorbable and permanent embolization materials in a rabbit model.
van den Esschert JW; van Lienden KP; Alles LK; van Wijk AC; Heger M; Roelofs JJ; van Gulik TM
Ann Surg; 2012 Feb; 255(2):311-8. PubMed ID: 22241291
[TBL] [Abstract][Full Text] [Related]
14. Effect of branched-chain amino acid supplementation on functional liver regeneration in patients undergoing portal vein embolization and sequential hepatectomy: a randomized controlled trial.
Beppu T; Nitta H; Hayashi H; Imai K; Okabe H; Nakagawa S; Hashimoto D; Chikamoto A; Ishiko T; Yoshida M; Yamashita Y; Baba H
J Gastroenterol; 2015 Dec; 50(12):1197-205. PubMed ID: 25847401
[TBL] [Abstract][Full Text] [Related]
15. Hepatic parenchymal transection increases liver volume but not function after portal vein embolization in rabbits.
Olthof PB; Schadde E; van Lienden KP; Heger M; de Bruin K; Verheij J; Bennink RJ; van Gulik TM
Surgery; 2017 Oct; 162(4):732-741. PubMed ID: 28173999
[TBL] [Abstract][Full Text] [Related]
16. Farnesoid X Receptor Agonist Treatment Alters Bile Acid Metabolism but Exacerbates Liver Damage in a Piglet Model of Short-Bowel Syndrome.
Pereira-Fantini PM; Lapthorne S; Gahan CGM; Joyce SA; Charles J; Fuller PJ; Bines JE
Cell Mol Gastroenterol Hepatol; 2017 Jul; 4(1):65-74. PubMed ID: 28560290
[TBL] [Abstract][Full Text] [Related]
17. Transarterial versus transhepatic portal vein embolization to induce selective hepatic hypertrophy: a comparative study in swine.
Madoff DC; Gupta S; Pillsbury EP; Kan Z; Tinkey PT; Stephens LC; Ensor JE; Hicks ME; Wright KC
J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):79-93. PubMed ID: 17296708
[TBL] [Abstract][Full Text] [Related]
18. Can plasma bile salt, triglycerides, and apoA-V levels predict liver regeneration?
Hoekstra LT; van Lienden KP; Schaap FG; Chamuleau RA; Bennink RJ; van Gulik TM
World J Surg; 2012 Dec; 36(12):2901-8. PubMed ID: 22955952
[TBL] [Abstract][Full Text] [Related]
19. Sequential preoperative ipsilateral hepatic vein embolization after portal vein embolization to induce further liver regeneration in patients with hepatobiliary malignancy.
Hwang S; Lee SG; Ko GY; Kim BS; Sung KB; Kim MH; Lee SK; Hong HN
Ann Surg; 2009 Apr; 249(4):608-16. PubMed ID: 19300228
[TBL] [Abstract][Full Text] [Related]
20. A Short Review on Obeticholic Acid: An Effective Modulator of Farnesoid X Receptor.
Narayanan AK; Surendran S; Balakrishnan D; Gopalakrishnan U; Malick S; Valsan A; Philips CA; Watson CJE
Curr Rev Clin Exp Pharmacol; 2024; 19(3):225-233. PubMed ID: 38708917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
